The laboratories participating in the QA21 EQA scheme for antimicrobial susceptibility testing of N. gonorrhoeae showed good levels of competency and capability in recovering and testing strains of unknown phenotype.
The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the European Union/European Economic Area (EU/EEA) is essential for detecting emerging and increasing antimicrobial resistance. Since 2009, this surveillance has been co-ordinated by the European Centre for Disease Prevention and Control (ECDC). The quality-assured data produced can be used to inform treatment guidelines.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-27 August 2022 and includes updates on monkeypox, West Nile virus, COVID-19, Ebola, Vibrio growth, diphtheria, cholera, chikungunya virus disease and dengue.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 December 2021 and includes updates on COVID-19, Ebola, influenza and MERS-CoV.
External quality assessment (EQA) is an essential part of any laboratory-based surveillance system, allowing for the monitoring of performance and comparability of results from participating laboratories, identification of potential issues and deployment of resources and training where necessary.
External quality assessment (EQA) is an essential part of any laboratory-based surveillance system, allowing for the monitoring of performance and comparability of results from participating laboratories, identification of potential issues and deployment of resources and training where necessary.